Palatin Technologies
PTN
#9923
Rank
ยฃ29.39 M
Marketcap
ยฃ17.26
Share price
4.59%
Change (1 day)
2,268.70%
Change (1 year)

Palatin Technologies (PTN) - Cash on Hand

Cash on Hand as of March 2025 : ยฃ1.89 Million

According to Palatin Technologies's latest financial reports the company has ยฃ1.89 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Palatin Technologies - Cash on Hand chart (from 1997 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30ยฃ7.53 M-12.81%
2023-06-30ยฃ8.63 M-64.91%
2022-06-30ยฃ24.61 M-43.36%
2021-06-30ยฃ43.46 M-35.01%
2020-06-30ยฃ66.87 M95.11%
2019-06-30ยฃ34.27 M19.14%
2018-06-30ยฃ28.76 M-7.49%
2017-06-30ยฃ31.09 M341.74%
2016-06-30ยฃ7.03 M-59.55%
2015-06-30ยฃ17.4 M144.37%
2014-06-30ยฃ7.12 M-55.65%
2013-06-30ยฃ16.05 M558.3%
2012-06-30ยฃ2.43 M-79.25%
2011-06-30ยฃ11.75 M101.09%
2010-06-30ยฃ5.84 M23.24%
2009-06-30ยฃ4.74 M-26.07%
2008-06-30ยฃ6.41 M-61.95%
2007-06-30ยฃ16.86 M0.57%
2006-06-30ยฃ16.77 M63.86%
2005-06-30ยฃ10.23 M-8.72%
2004-06-30ยฃ11.21 M0.57%
2003-06-30ยฃ11.15 M115.12%
2002-06-30ยฃ5.18 M-35.97%
2001-06-30ยฃ8.09 M127.78%
2000-06-30ยฃ3.55 M99.93%
1999-06-30ยฃ1.77 M-30.99%
1998-06-30ยฃ2.57 M-66.5%
1997-06-30ยฃ7.68 M75.97%
1996-06-30ยฃ4.36 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
MediciNova
MNOV
ยฃ25.71 M 1,259.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
ยฃ4.21 M 122.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.83 B 44,137.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ0.20 B 10,672.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.50 B 26,761.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ13.93 B 736,469.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
ยฃ0.18 B 9,530.92%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ6.14 B 324,574.81%๐Ÿ‡ฌ๐Ÿ‡ง UK